피부 악성 종양에서 EGFR의 발현과 금 나노 입자를 이용한 Molecular Labelling에 대한 연구 = The Study of EGFR Expression on Malignant Skin Tumor and Molecular Labelling Using Gold Nanoparticles피부 악성 종양에서 EGFR의 발현과 금 나노 입자를 이용한 Molecular Labelling에 대한 연구

다국어 초록 (Multilingual Abstract)

Background: The potential benefits of a molecular characterization of cancer are clear. Because of this, there is pressing need to perform in vivo imaging of the molecular features of cancer. However, before designing an appropriate molecular targeting technique utiilizing a cancer-related target molecule such as epidermal growth factor receptor (EGFR), it is necessary to characterize the exact expression of the target molecule. Objective: The objective of this study was twofold. Our first goal was to characterize the expression of EGFR in skin cancer, and second, to develop nanoparticles conjugated with antibodies, demonstrating their use as optical probes for detecting cancer cells in vitro. Methods: We performed immunhistochemical analysis of EGFR expression in skin cancer using monoclonal antibodies. Gold nanoparticles were synthesized and allowed to conjugate to anti-EGFR in epithelial cancer tissue. Following an incubabtion period, we recorded surface plasmon resonance images using gold nanoparticles conjugated to anti-EGFR antibodies. Results: Specific membranous binding of EGFR was detected in all of the 10 non-melanoma skin cancers. Surface plasmon resonance images using gold nanoparticles also showed light scattering around tumor cells. Conclusion: These ex vivo results demonstrate that optical imaging using gold nanoparticles can allow selective detection of human epithelial cancer cells. Our study demonstrates the potential of gold nanoparticles to target, probe, and illuminate cancer cells making them an effective biomolecular cancer detection tool. (Korean J Dermatol 2009;47(2):172∼179)

참고문헌 (Reference)

1 Mulvaney P, "The direct measurement of the forces of interaction between a colloid particle and an oil droplet" 183 : 614-616, 1996

2 EI-Sayed IH, "Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer" 5 : 829-834, 2005

3 Bruchez M Jr, "Semiconductor nanocrystals as fluorescent biological labels" 281 : 2013-2016, 1998

4 Gill GN, "Regulatory features of the epidermal growth factor recerptor" 5 : 35-41, 1987

5 van der Geer P, "Receptor protein- tyrosine kinases and their signal transduction pathways" 10 : 251-337, 1994

6 Sokolov K, "Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles" 63 : 1999-2004, 2003

7 Chan WC, "Quantum dot bioconjugates for ultrasensitive nonisotopic detection" 281 : 2016-2018, 1998

8 Heldin CH, "Protein tyrosine kinase receptors" 27 : 7-24, 1996

9 Sokolov K, "Optical systems for in vivo molecular imaging of cancer" 2 : 491-504, 2003

10 Huang D, "Optical coherence tomography" 254 : 1178-1181, 1991

11 Collier T, "Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue" 9 : 504-512, 2002

12 Weiner LM, "Monoclonal antibody therapy of cancer" 26 : 43-51, 1999

13 Kah JC, "Molecular contrast of EGFR expression using gold nanoparticles as a reflectance-based imaging probe" 22 : 14-23, 2008

14 Grizzle WE, "Molecular characterization of colorectal neoplasia in translational research" 125 : 91-98, 2001

15 Abrams MJ, "Metal compounds in therapy and diagnosis" 261 : 725-730, 1993

16 Tearney GJ, "In vivo endoscopic optical biopsy with optical coherence tomography" 276 : 2037-2039, 1997

17 Rajadhyaksha M, "In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast" 104 : 946-952, 1995

18 Choi KC, "Immunohistochemical study of TGFα, EGF and EGF receptor on the epithelial tumors of the skin" 32 : 438-445, 1994

19 Davies RL, "Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7" 77 : 4188-4192, 1980

20 Park ES, "Expression of epidermal growth factor recerptor in malignant epidermal tumors" 32 : 271-276, 1994

21 Lavrijsen AP, "Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin" 281 : 83-88, 1989

22 Nazmi MN, "Epidermal growth factor receptors in human epidermal tumours" 123 : 153-161, 1990

23 Shimizu T, "Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin" 202 : 203-206, 2001

24 Carpenter G, "Epidermal growth factor" 265 : 7009-7012, 1990

25 Holliger P, "Engineering antibodies for the clinic" 18 : 411-419, 1999

26 Yoshida K, "EGF and TGFα, the ligands of hyperproduced EGFR in human oesophageal carcinoma cells, act as autocrine growth factors" 45 : 131-135, 1990

27 Hudson LG, "Contributions of the epidermal growth factor receptor to keratinocyte motility" 43 : 444-455, 1998

28 Son KD, "Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin" 97 : 615-620, 2008

29 Horisberger M, "Colloidal gold: a cytochemical marker for light and fluorescent microscopy and for transmission and scanning electron microscopy" 2 : 9-31, 1981

30 Fogarty GB, "Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin" 156 : 92-98, 2007

31 Lee S, "Biological imaging of HEK293 cells expressing PLCgamma1 using surface-enhanced Raman microscopy" 79 : 916-922, 2007

32 Kikuchi A, "Association of EGF receptor expression with proliferating cells and of ras p21 expression with differentiating cells in various skin tumours" 123 : 49-58, 1990

33 West JL, "Applications of nanotechnology to biotechnology commentary" 11 : 215-217, 2000

34 Carraway KL 3rd, "A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling" 78 : 5-8, 1994